Safety, Tolerability and Pharmacokinetics Study of LY03005

NCT02055300 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY03005
DRUG: Placebo
OTHER: Meal
DRUG: Pristiq

Sponsor

Luye Pharma Group Ltd.